In vitro activity of temocillin, a new beta-lactamase-stable penicillin active against enterobacteria.
AUTOR(ES)
Greenwood, D
RESUMO
The activity of temocillin was investigated in vitro against 523 clinical isolates of enterobacteria and Pseudomonas aeruginosa. The minimum inhibitory concentration of the new compound for all ampicillin-susceptible enterobacteria and for 90% of ampicillin-resistant enterobacteria was 16 micrograms/ml or less, a concentration readily achieved in plasma. P. aeruginosa strains were uniformly resistant to temocillin. All but 3 of a separate group of 48 enterobacteria exhibiting resistance to the combination of clavulanic acid and amoxicillin were found to be inhibited by 16 micrograms or less of temocillin per ml. The new compound also displayed good activity against a group of laboratory stock cultures selected on the basis of differential resistance to presently available beta-lactam agents. Two of these strains were cefotaxime resistant.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=183709Documentos Relacionados
- In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin.
- In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.
- Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
- Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.
- Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.
